HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.
HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.
Opioids are high-risk medicines that are associated with significant harm or death when misused. A report commissioned by the Australian Institute of Health and Welfare (AIHW) highlights the harms caused by opioids. It shows…
Read more
From 1 April 2022, a new treatment for cystic fibrosis was listed on the Pharmaceutical Benefits Scheme (PBS). Trikafta® (elexacaftor, tezacaftor + ivacaftor) is an authority required item supplied under the Section 100 Highly…
Read more
The Australian Technical Advisory Group on Immunisation (ATAGI) has published advice on the use of seasonal influenza vaccines for 2022. Some of the key points include: Annual vaccination is recommended for all people six…
Read more
From 1 March 2022, eculizumab and ravulizumab are available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). This is an extension of indications for eculizumab which was listed…
Read more
Restrictive practice is an intervention or practice that restricts the rights or freedom of movement of the person. There are five restrictive practices in aged care – chemical restraint, environmental restraint, mechanical restraint, physical…
Read more
On 1 March 2022, molnupiravir became the first COVID-19 antiviral to be available on the Pharmaceutical Benefits Scheme (PBS). Molnupiravir is provisionally approved for the treatment of adults with COVID-19 who are at increased…
Read more
